Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Frataxin deficiency lowers lean mass and triggers the integrated stress response in skeletal muscle
César Vásquez-Trincado, Julia Dunn, Ji In Han, Briyanna Hymms, Jaclyn Tamaroff, Monika Patel, Sara Nguyen, Anna Dedio, Kristin Wade, Chinazo Enigwe, Zuzana Nichtova, David R. Lynch, Gyorgy Csordas, Shana E. McCormack, Erin L. Seifert
César Vásquez-Trincado, Julia Dunn, Ji In Han, Briyanna Hymms, Jaclyn Tamaroff, Monika Patel, Sara Nguyen, Anna Dedio, Kristin Wade, Chinazo Enigwe, Zuzana Nichtova, David R. Lynch, Gyorgy Csordas, Shana E. McCormack, Erin L. Seifert
View: Text | PDF
Research Article Muscle biology

Frataxin deficiency lowers lean mass and triggers the integrated stress response in skeletal muscle

  • Text
  • PDF
Abstract

Friedreich’s ataxia (FRDA) is an inherited disorder caused by reduced levels of frataxin (FXN), which is required for iron-sulfur cluster biogenesis. Neurological and cardiac comorbidities are prominent and have been a major focus of study. Skeletal muscle has received less attention despite indications that FXN loss affects it. Here, we show that lean mass is lower, whereas body mass index is unaltered, in separate cohorts of adults and children with FRDA. In adults, lower lean mass correlated with disease severity. To further investigate FXN loss in skeletal muscle, we used a transgenic mouse model of whole-body inducible and progressive FXN depletion. There was little impact of FXN loss when FXN was approximately 20% of control levels. When residual FXN was approximately 5% of control levels, muscle mass was lower along with absolute grip strength. When we examined mechanisms that can affect muscle mass, only global protein translation was lower, accompanied by integrated stress response (ISR) activation. Also in mice, aerobic exercise training, initiated prior to the muscle mass difference, improved running capacity, yet, muscle mass and the ISR remained as in untrained mice. Thus, FXN loss can lead to lower lean mass, with ISR activation, both of which are insensitive to exercise training.

Authors

César Vásquez-Trincado, Julia Dunn, Ji In Han, Briyanna Hymms, Jaclyn Tamaroff, Monika Patel, Sara Nguyen, Anna Dedio, Kristin Wade, Chinazo Enigwe, Zuzana Nichtova, David R. Lynch, Gyorgy Csordas, Shana E. McCormack, Erin L. Seifert

×

Figure 1

Lower lean mass in FRDA adults correlates with increased FRDA clinical disease severity.

Options: View larger image (or click on image) Download as PowerPoint
Lower lean mass in FRDA adults correlates with increased FRDA clinical d...
(A) Body composition z scores in healthy adults (n = 24) and adults with FRDA (n = 24). Two-tailed t tests between the 2 groups revealed that while there was no difference between the fat mass index (FMI) z scores in adults with and without FRDA, lean BMI (LBMI) was lower in adults with FRDA (–1.31 ± 1.21) compared with those without (–0.67 ± 0.87) (difference of –0.64; 95% CI, –1.25 to –0.02; P = 0.04). The same was true for appendicular lean mass index (ALMI) z scores, which were –1.61 ± 1.38 for individuals with FRDA and –0.5 ± 1.02 for those without (difference of –1.11; 95% CI, –1.82 to –0.41, P = 0.003), and for ALMI adjusted for fat mass, which were –2.41 ± 1.69 for adults with FRDA and –0.55 ± 1.47 for adults without FRDA (difference of –1.86; 95% CI, –2.78 to –0.95; P = 0.0002). (B) Body composition z scores in pediatric participants with FRDA (n = 10). One-tailed t tests comparing z scores from children with FRDA to 0, the expected mean z score based on the reference population, revealed no difference between the height and BMI z scores of children with FRDA and a population of healthy children with an average z score of 0. FMI was higher in children with FRDA (0.56 ± 0.73, 95% CI, 0.04 to 1.08; P = 0.04) while LBMI was lower than expected in children with FRDA (–2.45 ± 1.65, 95% CI, –3.63 to –1.27; P = 0.001). The box plots depict the minimum and maximum values (whiskers), the upper and lower quartiles, and the median. The length of the box represents the interquartile range. (C) Pearson’s correlation between fat-adjusted ALMI z score and modified Friedreich’s Ataxia Rating Scale (mFARS) scores, a marker of clinical severity, in adults with FRDA. R = –0.5; 95% CI, –0.76 to –0.11; P = 0.02.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts